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Abstract
We reported a challenging transvenous lead extraction procedure for lead failure in
a child with congenital heart disease. Our report demonstrates that the new hand-
powered bidirectional rotational Evolution RL (Cook Medical, USA) mechanical
extraction sheath is an effective and safe tool for the extraction of chronically
implanted leads in children.
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1 | INTRODUCTION
Several large series have investigated the different transvenous lead
extraction (TLE) techniques and their safety and efficacy in adult
patients with and without congenital heart disease (CHD).1,2 How-
ever, data on lead extraction in pediatric and (CHD) patients remain
limited.3,4 The new Evolution mechanical sheath (Evolution RL, Cook
Medical, USA) is an effective and safe tool for the extraction of
chronically implanted leads when advanced techniques are required
in adults.5 However, data on safety and efficacy of the new Evolu-
tion sheath in children with CHD undergoing TLE are still lacking.
2 | CASE REPORT
We reported a case of an 11-year-old boy referred to our center for
TLE because of failure of the PM lead (Medtronic Capsure MRI
SureScan 5086, active fixation). At 2 years old, he underwent surgi-
cal correction of a complete atrioventricular (AV) septal defect com-
plicated by complete AV block. A single-chamber transvenous PM
was implanted through the right subclavian vein, because of persis-
tent left superior vena cava.
Nine years later, during a routine device interrogation, a signifi-
cant increase in pacing threshold and decrease in pacing impedance
of the lead were observed. Chest radiography revealed the entrap-
ment of the lead between the right clavicle and the first rib, suggest-
ing a possible loss of the lead insulation (Figure 1, Panel A). Contrast
venography showed important adherences at the right subclavian
and superior vena cava (Figure 1, Panel B). We tried to puncture the
right subclavian or axillary vein, but the guidewire (including hydro-
philic wire) failed to advance through the vein because of an
obstruction. Due to the young age, the ipsilateral vein obstruction,
the presence of persistent left superior vena cava, we decided to
extract the lead and to implant a new lead.
The procedure was performed in a hybrid operating room under
general anesthesia, arterial blood pressure monitoring, and trans-
esophageal echocardiographic guidance. In addition, a stiff guidewire
from the right femoral vein to the right internal jugular vein for
potential use of the bridge occlusion balloon (Spectranetics, Color-
ado Springs, CO) in case of vascular lacerations was deployed.
Before the procedure, contrast venography showed important
adherences at the right subclavian and superior vena cava (Figure 1,
Panel B). After the pocket was opened and the generator removed,
it was immediately clear that it was impossible both to retract the
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active fixation screw and to advance the locking stylet to the lead
tip, because of the lead fracture under the right clavicle. Thus, after
prepping the lead with an extender (Bulldog, Cook Medical, Bloo-
mington, IN, USA), an 9Fr Evolution RL, an 9Fr RL Shortie mechani-
cal dilator sheaths (Cook Medical, USA), and an outer sheath were
advanced into the right subclavian vein, but failed to advance fur-
ther, because of tenacious fibrotic adherences in the superior vena
cava (Figure 1, Panel C). After several attempts and adjustments,
using first an 11Fr and then an 13Fr Evolution RL sheaths, we were
finally able to advance to the vena cava, to free the lead of any scar
tissue, and to withdraw it through the sheath without complications
(Figure 1, Panel D-F). A guidewire was placed down the Evolution
shortie sheath through the same vein for new PM implantation.
Echocardiography showed no tricuspid valve regurgitation and no
pericardial effusion. A new single-chamber PM was then implanted,
from the right subclavian vein. After 3 months of follow-up, the
patient was asymptomatic, the incision healed cleanly, and the PM
was functioning properly.
3 | DISCUSSION
Over the past decade, transvenous PM and defibrillator implanta-
tions in pediatric and CHD patients have markedly increased. These
devices are often placed at a young age, and with improved survival,
the life span of the patient often exceeds that of the device.
Patients with CHD experience higher rates of lead malfunction and
infection when compared with older individuals with structurally nor-
mal hearts.
Despite improvements to extraction techniques, transvenous lead
removal is still a challenging procedure, especially when leads are
chronically implanted, and is associated with potential procedural
failure, morbidity, and life-threatening complications.1,2 Chronically
implanted leads develop fibrous adhesions around surrounding struc-
tures and thus require different extraction sheaths, such as mechani-
cal sheaths, laser sheaths, or electrosurgical dissection sheaths.1,2
A recent large study by Fender et al.3 reported information
regarding TLE in CHD patients compared with a control group. With
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F IGURE 1 Chest radiography showed the entrapment of the lead between the right clavicle and the first rib, suggesting a possible
loss of the lead insulation, arrow (Panel A). Contrast venography showed important adherences at the right subclavian and superior vena
cava, arrows (Panel B). An 9Fr Evolution RL mechanical dilator sheath and an outer sheath were advanced into the right subclavian vein
(Panel C). An 13Fr Evolution RL sheaths with an outer sheath were advanced over the lead, and it was withdrawn through the sheath in
the absence of any complications (Panel D-E). Extracted lead. Of note, the presence of important fibrous material adherent to the lead
(Panel F)
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the use of almost all techniques available for TLE, they concluded
that lead extraction can be safely performed in patients with CHD
and despite anatomic abnormalities and longer implantation times,
the difficulty of lead extraction in patients with CHD is comparable
with controls.3 Checchin et al. also reported that in pediatric and
CHD population older lead age, ventricular leads, and polyurethane
insulation were independent predictors of the decreased likelihood
of an extraction by simple traction.4 These are established indepen-
dent predictors of most difficult procedures also in the population
without CHD. These results suggest that TLE can be safely per-
formed in patients with CHD.
The new Evolution sheath (Evolution RL, Cook Medical, USA)
with its bidirectional rotational mechanism and redesigned tip is an
effective and safe tool for the extraction of chronically implanted
leads when advanced techniques are required.5 However, data on
safety and efficacy of the new Evolution sheath in children with
CHD undergoing lead extraction are still lacking.
In our case, a guidewire was placed down the Evolution shortie
sheath through the same vein for new lead implantation. Probably, it
has a repeated risk of lead fracture, as the new lead was implanted
through the same course of the previous lead which was fractured
by the friction at the right clavicle. However, in our experience, this
procedure is not the same as how to puncture the vein at the same
point as before. Moreover, lead extraction to regain venous access
of an occluded vein preserves the contralateral side for potential
future use and minimizes overall lead burden, especially in children.
Although this is only a single clinical case, our report demonstrates
the safeness and feasibility of challenging lead extraction using the
Evolution RL mechanical lead extraction sheath in children with CHD
and chronically implanted leads. Large prospective studies should be
conducted in the future to verify our findings and compare the clinical
success, safety, and cost-effectiveness of different TLE devices.
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